Clinical and pathological response after neoadjuvant chemotherapy with or without zoledronic acid for patients with HER2-negative large resectable or stage II or III breast cancer
Author(s):
Charehbili, A.; Ven, S. van de; Liefers, G.J.; Smit, V.T.; Wasser, M.N.; Kranenbarg, E.M.M.K.; Leeuwen-Stok, A.E. van; Velde, C.J.H. van de (0000-0003-0104-1800); Nortier, J.W.R.; Kroep, J.R.
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-09-30
Language
English
Is part of
European Journal of Cancer (2013), Vol. 49, p. S401-S401
